https://www.indianpharmapost.com/zydus-receives-tentative-approval-from-usfda-for-bosentan-tablets-for-oral-suspension-137282023-02-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-tentative-approval-from-the-usfda-for-canagliflozin-tablets-137292023-02-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/aurobindo-pharma-gets-vai-classification-from-usfda-for-telangana-plant-137302023-02-16T00:00:00+05:30always0.9https://www.indianpharmapost.com/panacea-biotec-posts-q3-fy2023-net-profit-at-rs1937-crores-137312023-02-16T00:00:00+05:30always0.9